• Skip to main content
ISC
ISC
  • Program
  • #ISC26
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
Resources
  • Program
  • #ISC26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon YouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
Resources
  • Program
  • #ISC26
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon YouTube iconPinterest iconLinkedIn icon

Late-Breaking Science

From left to right: Ángel Chamorro, Joseph Broderick and Ronald M. Lazar.
CHOICE-2, FASTEST and CREST 2 results revealed during Opening Main Event
Researchers presented their findings on three Late-Breaking Science trials at the Opening Main Event of #ISC26 on Wednesday.
Feb 5th, 2026
Audiance 0088
Don’t miss all of the exciting Late-Breaking Science at #ISC26
Jan 16th, 2026
Lb 03 Audience
#ISC26 Closing Main Event reports on SPAN2, I-ACQUIRE, LAIS, LUMOSA, CONCERN, MeVO, DISTALS and BCI-REHAB trials
Feb 9th, 2026
Lbs02 Audience
Late-Breaking Science reveals findings on adjunct intra-arterial thrombolysis, TNK, tirofiban and more
Feb 9th, 2026
Getty Images 490850200
ISC26 Fireside Chats
Jan 23rd, 2026
ISC audience
Late breakers report on DOACs reducing ischemic stroke risk, thrombolysis with tenecteplase following successful thrombectomy and more
Feb 12th, 2025
LBS stage shot
Late-breaking trials explore issues related to BP care, statin, recovery and more
Feb 10th, 2025
Stroke Risks and Prevention
Sponsored
Stroke Risks and Prevention
The importance of providing care throughout the continuum of care for stroke patients, including identifying a patient’s risk factors, goals, needs and abilities. CE credit available.
Jan 8th, 2026
audience
Late-breaking results from five trials presented at Opening Main Event
Feb 6th, 2025
audience shot
#ISC25 Main Events and hot topics
Mark your calendar for these exciting sessions planned for ISC25. You will not want to miss them!
Jan 16th, 2025
audience shot
#ISC25 Late-Breaking Science oral abstracts
Get more information on these select Late-Breaking Science oral abstracts on Wednesday, Feb. 5, and Thursday, Feb. 6.
Jan 10th, 2025
audience shot
Oral concurrent abstract sessions at #ISC25
Make time to take in these concurrent abstract sessions on Wednesday, Feb. 5, and Thursday, Feb. 6.
Dec 12th, 2024
ISC audience
Late-Breaking Science announced for #ISC25
#ISC25 will present the results from 19 late-breaking science studies during the Main Events each day.
Dec 12th, 2024
audience shot
10 Late-Breaking Science presentations highlight Closing Main Event
Feb 14th, 2024
24 Isc Lbs02 Audience1
TREND, SPAN, RODIN and GOLDEN BRIDGE-II results revealed
Feb 12th, 2024
24 Isc 04652
ZODIAC, RESILIENT-Extend and MOST Late-Breaking Science presented
Three Late-Breaking Science results delivered at the #ISC24 Opening Session.
Feb 7th, 2024
Audience picture
Final Late-Breaking Science announced for ISC 2024
Jan 22nd, 2024
audience shot
Late-Breaking Science announced for ISC 2024
Jan 12th, 2024
Getty Images 861104740
2023 Late-Breaking Science: BEST-II, CATIS-2, ANGEL-ASPECT, SELECT 2, ARAMIS, RESCUE BT2 and CMOSS
Feb 13th, 2023
stroke image
2023 Late Breaking Science: Improving stroke thrombolysis, comparing tenecteplase and alteplase, and treating cognitive decline after lacunar stroke
Feb 9th, 2023
Getty Images 987986472
2023 Late-Breaking Science: SPAN results, monitoring ischemic stroke in small- and large-vessel disease and positive neuroprotective effects from aptamer
Feb 8th, 2023
Getty Images 1129515493
Stroke simultaneous publications from ISC 2023
Feb 8th, 2023
audience listening to a presentation
Schedule of Main Events
Jan 24th, 2023
Stroke audience
Late-Breaking Science for #ISC23
Dec 26th, 2022
abstract images of a pulse
Trials’ results shed light on new technology for preventing stroke, best practices and devices for LVO retrieval, the effectiveness of antiplatelet therapy with the addition of cilostazol and mechanical thrombectomy in pediatric patients with LVO
Feb 12th, 2022
Abstract representative of a heart pulse
Trials’ results highlight the cost-effectiveness of mobile stroke units and point to advancements in treatment approaches for patients with LVO, cerebral venous thrombosis and cerebral arteriovenous malformation
Feb 10th, 2022
Getty Images 994777970
Endovascular therapy, tirofiban for LVO and periodontal care highlight late-breaking science
Feb 10th, 2022